Inspire Medical Systems, Inc.

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Revenue $28.6m $50.6m $82.0m $115.4m $233.4m $407.9m $624.8m $802.8m $912.0m
Cost of goods sold $6.0m $10.1m $13.6m $17.6m $33.3m $66.1m $96.6m $123.0m $133.2m
Gross profit $22.5m $40.5m $68.4m $97.8m $200.1m $341.7m $528.2m $679.8m $778.8m
Research and development $6.2m $7.4m $12.8m $26.1m $37.4m $68.6m $116.5m $114.1m $103.2m
Selling, general and administrative $32.4m $53.5m $90.5m $127.9m $202.6m $320.7m $452.0m $529.6m $624.6m
Total operating expenses $38.6m $60.9m $103.3m $154.0m $240.0m $389.3m $568.5m $643.7m $727.8m
Operating income (loss) ($16.0m) ($20.4m) ($34.9m) ($56.2m) ($39.9m) ($47.6m) ($40.3m) $36.1m $51.0m
Interest and dividend income ($1.1m) ($125k) ($5.0m) ($20.6m) ($23.2m) ($17.5m)
Income (loss) before income taxes ($17.5m) ($21.8m) ($33.2m) ($57.1m) ($42.0m) ($44.3m) ($19.9m) $58.5m $65.7m
Foreign currency translation (loss) gain $0 $0 $89k $140k ($65k) ($296k)
Unrealized gain (loss) on investments $0 ($52k) $154k ($73k) ($84k) ($120k) $746k ($199k) $224k
Total other income $1.5m $1.4m ($1.7m) $880k $2.1m ($3.3m) ($20.4m) ($22.4m) ($14.7m)
Total comprehensive income (loss) ($17.5m) ($21.9m) ($33.1m) ($57.3m) ($42.1m) ($44.9m) ($20.3m) $53.2m $145.3m
Net income (loss) ($17.5m) ($21.8m) ($33.2m) ($57.2m) ($42.0m) ($44.9m) ($21.2m) $53.5m $145.4m
Basic (in dollars per share) ($1.40) ($2.19) ($1.54) ($1.60) ($0.72) $1.80 $4.95
Diluted (in dollars per share) ($1.40) ($2.19) ($1.54) ($1.60) ($0.72) $1.75 $4.89
Interest expense $1.8m $3.3m $2.1m $2.1m $2.1m $1.7m $0 $22k $137k
Other expense, net ($42k) $16k ($12k) ($145k) $117k $49k $195k $855k $2.7m
Income tax (benefit) expense $0 $0 $40k $115k $72k $613k $1.2m $4.9m ($79.7m)